Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001372815 | SCV001569504 | likely benign | Jeune thoracic dystrophy; Nephronophthisis | 2024-09-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488179 | SCV002787601 | uncertain significance | Asphyxiating thoracic dystrophy 4; Nephronophthisis 12 | 2022-02-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002548665 | SCV003714813 | uncertain significance | Inborn genetic diseases | 2021-08-13 | criteria provided, single submitter | clinical testing | The c.1883G>A (p.R628H) alteration is located in exon 14 (coding exon 14) of the TTC21B gene. This alteration results from a G to A substitution at nucleotide position 1883, causing the arginine (R) at amino acid position 628 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |